Factor viii level comparison in patients with severe hemophilia a on emicizumab with inhibitors with one stage, bovine and human chromogenic assays and the factor viii equivalency of emicizumab using in vivo global hemostasis assays
Blood（2023）
摘要
Introduction
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要